Privacy Policy – KANHA-MED-Two Worlds. One Standard of Care

Effective Date: [02-05-2026]
Brand Name: KANHA-MED
Parent Entity: SMSPA Enterprises (Proprietorship: Roopesh Sachan)

At KANHA-MED, we operate as a dedicated B2B (Business-to-Business) distribution and manufacturing platform. This Privacy Policy outlines how we handle data for our registered retailers and wholesalers.

1. THE ENTITY

WWW.KANHAMED.COM and the brand KANHA-MED are operated by SMSPA Enterprises, a proprietorship firm owned by Mr. Roopesh Sachan. All legal obligations and data processing are managed under this parent entity.

2. BUSINESS SCOPE & DATA COLLECTION

We facilitate the online and offline distribution of:

Human & Veterinary Medicines
Surgical Products
Contract Manufacturing Services (for private labels and third-party formulations)

To maintain the integrity of the pharmaceutical supply chain, we collect:

Business Credentials: GSTIN, Valid Drug Licenses (Retail/Wholesale), and PAN.
Authorized Representative Details: Name, contact number, and email of the proprietor or authorized buyer.
Transaction Data: Order history, billing details, and manufacturing specifications for contract orders.

3. MANDATORY REGISTRATION

Guest Access: Unregistered users may browse the website catalog but are strictly prohibited from viewing trade prices or placing orders.
Mandatory On boarding: Full access to the B2B portal is granted only after a successful registration process and verification of Drug Licenses and GSTIN.
Verification: By registering, you consent to the verification of your licenses with the respective State/Central Licensing Authorities.

4. B2B DISTRIBUTION MODEL

We serve two primary segments:

Retailers: Localized distribution within the district.
Wholesalers: PAN-India distribution and bulk supply.
Data collected is used to optimize logistics, manage credit limits (where applicable), and ensure compliance with the Drugs and Cosmetics Act.

5. THIRD-PARTY & CONTRACT MANUFACTURING DATA

Product Sourcing: We deal in both Own Brand products and Third-Party brands. Information regarding your inventory choices is kept confidential.
Manufacturing Confidentiality: For clients using our Contract Manufacturing services, all formulations, branding assets, and proprietary technical data are protected under strict non-disclosure protocols.

6. DATA SHARING & COMPLIANCE

We share your data only with:

Logistics Partners: For fulfillment of orders across India.
Government Authorities: To comply with mandatory reporting of Schedule H or controlled substance sales.
Payment Gateways: For secure processing of B2B transactions.

7. SECURITY OF PROFESSIONAL DATA

As a pure B2B firm, we recognize that your business data is sensitive. We use industry-standard encryption to ensure that your license documents and trade secrets remain protected from unauthorized access.

8. CONTACT & GRIEVANCE

For any queries regarding your registration or data usage, please contact:
Proprietor: Roopesh Sachan
Entity: SMSPA Enterprises
Email: smspaenterprises@gmail.com

B2B REFUND & CANCELLATION POLICY

Brand: KANHA-MED
Proprietor: Roopesh Sachan (SMSPA Enterprises)

As a dedicated B2B platform dealing with pharmaceutical and surgical products, our policies are governed by the Drugs and Cosmetics Act, 1940, and GST regulations regarding “Time Expired Drugs”.

1. CANCELLATION POLICY

Standard B2B Orders: Cancellations are only permitted before the order is “Dispatched” or within 24 hours of placing the order, whichever is earlier.
Post-Dispatch: Once products are shipped, cancellations are generally not allowed due to the sensitive nature of medicinal storage and safety requirements.
Contract Manufacturing: Cancellation is strictly prohibited once the production process or raw material procurement has commenced, as these products are custom-made to your specific branding and formulation needs.

2. RETURN ELIGIBILITY (STRICTLY B2B)

In the pharmaceutical trade, returns are an exception, not a rule. Returns are only accepted in the following cases:

Wrong Product/Quantity: If the items delivered do not match the Tax Invoice or your registered order.
Damaged in Transit: If the outer or inner packaging (seals, vials, or bottles) is visibly broken at the time of delivery.
- Requirement: Mandatory unboxing video and immediate written intimation to the delivery personnel and our support team.
Near-Expiry/Expired Stock: For standard distribution, “Near-Expiry” is defined as medicines having less than 3 months of remaining shelf life at the time of delivery.
Quality Defect: Suspected manufacturing defects must be reported immediately with batch details for verification by our quality team.

3. NON-RETURNABLE ITEMS

Temperature-Sensitive Products: Injections, vaccines, and products requiring a cold chain (refrigerated storage) cannot be returned once they leave our controlled environment.
Opened/Partially Used Stock: Partially consumed strips, opened bottles, or products with damaged labels.
Incorrect Ordering: Returns requested due to a “change of mind” or buyer’s ordering error are not entertained.

4. REFUND & ADJUSTMENT PROCESS

Credit Note (Preferred B2B Method): In accordance with Circular No. 72/46/2018-GST, refunds for returned goods are typically issued via a Credit Note. This value is adjusted against your next purchase invoice.
Bank Refunds: If a refund is approved for a prepaid order that cannot be fulfilled (e.g., out of stock), the amount will be credited to the original payment source within 7-10 working days.
Verification: All returns are subject to physical inspection. If the Batch Number does not match our invoice records, the return will be rejected.

5. CONTRACT MANUFACTURING REFUNDS

Refunds for contract manufacturing are limited to manufacturing defects confirmed by lab analysis.
KANHA-MED/SMSPA Enterprises is not liable for losses due to the client’s failure to market the product or regulatory changes affecting the client’s brand.

USER REGISTRATION & COMPLIANCE AGREEMENT

This Agreement governs the registration and onboarding process on kanhamed.com, a B2B platform operated by SMSPA Enterprises (Proprietor: Roopesh Sachan). By clicking “Register” or “I Agree,” you (the “User”) acknowledge and agree to the following terms:

1. MANDATORY ELIGIBILITY

Access to trade prices and the ability to purchase human/veterinary medicines or surgical products is restricted strictly to business entities. To register, you must possess:

Valid Drug License: Form 20, 21 (Retail) or Form 20B, 21B (Wholesale) as per the Drugs and Cosmetics Act, 1940.
GSTIN: A valid Goods and Services Tax Identification Number.
Professional Status: You must be a licensed pharmacist, doctor, registered medical practitioner, or a licensed pharmaceutical distributor.

2. VERIFICATION PROCESS

Document Submission: You agree to upload clear, scanned copies of your Drug License and GST Certificate during registration.
Authentication: KANHA-MED reserves the right to verify these documents through government portals (OCMMS, GSTN) or physical site visits.
Approval Timeline: Accounts are created in a “Pending” state. Trading privileges are only activated after our compliance team approves the documents (typically within 24–48 hours).

3. ACCURACY OF INFORMATION

You represent that all information provided is true and current. You must immediately update your profile on kanhamed.com if:

Your Drug License is renewed, suspended, or cancelled.
There is a change in the Constitution of the Firm (e.g., change from Proprietorship to Partnership).
Your Registered Premise address changes.

4. ACCOUNT SECURITY & ACCESS

Non-Transferability: Your KANHA-MED account is non-transferable. You are responsible for all orders placed using your credentials.
Guest Access: You acknowledge that Guest Users (unregistered) can only view the catalog. Any attempt to bypass the registration wall to view trade secrets or pricing is a violation of this agreement.

5. REGULATORY COMPLIANCE

Scheduled Drugs: You agree to maintain all records for the purchase of Schedule H, H1, or X drugs as mandated by law.
Usage: Products purchased from KANHA-MED are for Resale or Professional Use only and are not for personal consumption.

6. INDEMNITY

The User agrees to indemnify and hold Roopesh Sachan and SMSPA Enterprises harmless against any legal actions, penalties, or losses arising from the User’s submission of expired, forged, or invalid licenses.

7. TERMINATION OF ACCESS

KANHA-MED reserves the right to terminate or freeze your account without notice if:

Your Drug License expires and is not updated.
You are found to be “re-selling” to unlicensed individuals.
There is a default in payments or fraudulent activity.

CONTRACT MANUFACTURING & THIRD-PARTY DISCLAIMER

This disclaimer applies to all manufacturing services provided by SMSPA Enterprises (KANHA-MED) for third-party clients (“Brand Owners”).

1. INTELLECTUAL PROPERTY & BRANDING

Ownership: The Brand Owner represents that they own the trademark, brand name, and logo provided to KANHA-MED for printing on packaging/labels.
Infringement: SMSPA Enterprises shall not be held liable for any trademark or copyright infringement disputes arising from the brand name chosen by the client. The responsibility to ensure the brand name does not conflict with existing pharmaceutical brands rests solely with the Brand Owner.

2. FORMULATION & QUALITY

Standards: KANHA-MED guarantees that all products are manufactured in compliance with GMP (Good Manufacturing Practices) and the specifications agreed upon in the technical data sheet.
Raw Materials: Where the Brand Owner provides specific raw materials or active pharmaceutical ingredients (APIs), KANHA-MED is not responsible for defects arising from the inherent quality of such supplied materials.

3. REGULATORY COMPLIANCE & LABELLING

Approvals: While KANHA-MED assists in obtaining the necessary manufacturing licenses for the specific formulation, the Brand Owner is responsible for ensuring their marketing claims (on websites, brochures, or ads) comply with the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954.
Statutory Warnings: All labels will include statutory warnings as per the Drugs and Cosmetics Act. Any request by the Brand Owner to omit or alter legal labelling requirements will be rejected.

4. LIMITATION OF LIABILITY

Market Risks: SMSPA Enterprises and its proprietor, Roopesh Sachan, are not liable for the commercial failure, loss of profit, or lack of market demand for the products manufactured under contract.
Third-Party Claims: The Brand Owner shall indemnify KANHA-MED against any third-party claims, legal suits, or government penalties resulting from the distribution, side effects (unless proven to be a manufacturing defect), or off-label use of the product.

5. PRODUCT RECALLS

In the event of a product recall due to a manufacturing defect, KANHA-MED’s liability is limited to the replacement of the specific batch or a refund of the manufacturing cost. We are not liable for the Brand Owner’s secondary costs, such as logistics or marketing losses.